ChREBP regulates fructose-induced glucose production independently of insulin signaling
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Obese, insulin-resistant states are characterized by a paradoxical pathogenic condition in which the liver appears to be selectively insulin resistant. Specifically, insulin fails to suppress glucose production, yet successfully stimulates de novo lipogenesis. The mechanisms underlying this dysregulation remain controversial. Here, we hypothesized that carbohydrate-responsive element-binding protein (ChREBP), a transcriptional activator of glycolytic and lipogenic genes, plays a central role in this paradox. Administration of fructose increased hepatic hexose-phosphate levels, activated ChREBP, and caused glucose intolerance, hyperinsulinemia, hypertriglyceridemia, and hepatic steatosis in mice. Activation of ChREBP was required for the increased expression of glycolytic and lipogenic genes as well as glucose-6-phosphatase (G6pc) that was associated with the effects of fructose administration. We found that fructose-induced G6PC activity is a major determinant of hepatic glucose production and reduces hepatic glucose-6-phosphate levels to complete a homeostatic loop. Moreover, fructose activated ChREBP and induced G6pc in the absence of Foxo1a, indicating that carbohydrate-induced activation of ChREBP and G6PC dominates over the suppressive effects of insulin to enhance glucose production. This ChREBP/G6PC signaling axis is conserved in humans. Together, these findings support a carbohydrate-mediated, ChREBP-driven mechanism that contributes to hepatic insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“This is in line with the results from some studies in that hepatic esterification of FAs into TG, unlike DNL, depends on substrate delivery rather than insulin action [84-86].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [86]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ChREBPβ is transcriptionally induced by ChREBPα and amplifies the glucose response in the liver and adipose tissue [78,86].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [86]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Supporting this perspective, monosaccharides have been shown to activate ChREBP and other key lipogenic transcription factors—including SREBP1c, LXR, and PPARγ—via insulin-independent mechanisms [34,70,83,86,99].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [86]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the Western diet not only contains large amounts of AGEs, due to high levels of food processing, but is also high in fat and sugar, particularly fructose, which increases AGE production in the body, in part, by increasing circulating glucose levels via enhanced hepatic glucose production and insulin resistance.[4]”
From The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction (2021) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In response to the intake of large carbohydrates, fructose could enhance hepatic lipogenic capacity by inducing hepatic master transcription factors.93 94 95”
From Dietary sugar consumption and health: umbrella review (2023) · cites this paper as [94]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism
Taniguchi, C. M., Ueki, K., & Kahn, C. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23187 · Cited by 272
RetractedA SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 1×
“These studies do not address the observation that hyperinsulinemia fails to suppress hepatic glucose-6-phosphatase ( G6PC ) expression in insulin-resistant humans (12), a condition where increased DNL in association with steatosis and hypertriglyceridemia is readily apparent (13, 14).”
BackgroundSugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes
Malik, V. S., Popkin, B. M., Bray, G. A., Després, J.-P., Willett, W. C., & Hu, F. B. (2010) · Diabetes Care · doi:10.2337/dc10-1079 · Cited by 2,116
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322 · cited 1×
“However, others reported that defects in hepatic insulin signaling occur at the level of the insulin receptor, proximal to the proposed branch points in insulin signaling, thereby precluding differential insulin signaling as a mechanism to explain this paradox (7).”
BackgroundSelective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 965
SHIMOMURA, I. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00009-5 · Cited by 855
Iizuka, K., Bruick, R. K., Liang, G., Horton, J. D., & Uyeda, K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401516101 · Cited by 785
Li, S., Brown, M. S., & Goldstein, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914798107 · Cited by 733 · cited 1×
“…gluconeogenic enzyme gene expression, might be impaired, while insulin-mediated stimulation of a mechanistic target of rapamycin (MTOR)/sterol regulatory element–binding transcription factor 1 (SREBPF1 or SREBP1) signaling axis, which upregulates a DNL gene program, remains intact (5).”
BackgroundPerry, R. J., Camporez, J.-P. G., Kursawe, R., Titchenell, P. M., Zhang, D., Perry, C. J., Jurczak, M. J., Abudukadier, A., Han, M. S., Zhang, X.-M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.012 · Cited by 719 · cited 2×
“It has also been suggested that insulin’s acute effect of reducing hepatic glucose production (HGP) is independent of hepatic insulin signaling altogether and instead depends on suppression of adipose lipolysis and delivery of fatty-acid substrate to the liver (8, 9).”
BackgroundNakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
Matsumoto, M., Pocai, A., Rossetti, L., DePinho, R. A., & Accili, D. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.006 · Cited by 615
A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism
Herman, M. A., Peroni, O. D., Villoria, J., Schön, M. R., Abumrad, N. A., Blüher, M., Klein, S., & Kahn, B. B. (2012) · Nature · doi:10.1038/nature10986 · Cited by 596
Self-citationUyeda, K., & Repa, J. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.06.008 · Cited by 529
Schwarz, J.-M., Linfoot, P., Dare, D., & Aghajanian, K. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.1.43 · Cited by 496
Liver-Specific Inhibition of ChREBP Improves Hepatic Steatosis and Insulin Resistance in ob/ob Mice
Dentin, R., Benhamed, F., Hainault, I., Fauveau, V., Foufelle, F., Dyck, J. R. B., Girard, J., & Postic, C. (2006) · Diabetes · doi:10.2337/db06-0200 · Cited by 433
Hormonal regulation of hepatic glucose production in health and disease
Lin, H. V., & Accili, D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.003 · Cited by 429
Benhamed, F., Denechaud, P.-D., Lemoine, M., Robichon, C., Moldes, M., Bertrand-Michel, J., Ratziu, V., Serfaty, L., Housset, C., Capeau, J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci41636 · Cited by 408 · cited 1×
“Nuclear translocation of ChREBP-α may be important for CHO-mediated activation (41–43).”
BackgroundGlucokinase and molecular aspects of liver glycogen metabolism
Agius, L. (2008) · Biochemical Journal · doi:10.1042/bj20080595 · Cited by 384
ChREBP•Mlx Is the Principal Mediator of Glucose-induced Gene Expression in the Liver
Ma, L., Robinson, L. N., & Towle, H. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601576200 · Cited by 373
Kawaguchi, T., Takenoshita, M., Kabashima, T., & Uyeda, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231370798 · Cited by 373
Buescher, J. M., Moco, S., Sauer, U., & Zamboni, N. (2010) · Analytical Chemistry · doi:10.1021/ac100101d · Cited by 340
Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides
Kooner, J. S., Chambers, J. C., Aguilar-Salinas, C. A., Hinds, D. A., Hyde, C. L., Warnes, G. R., Gómez Pérez, F. J., Frazer, K. A., Elliott, P., Scott, J., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.61 · Cited by 334
De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health
Eissing, L., Scherer, T., Tödter, K., Knippschild, U., Greve, J. W., Buurman, W. A., Pinnschmidt, H. O., Rensen, S. S., Wolf, A. M., Bartelt, A., et al. (2013) · Nature Communications · doi:10.1038/ncomms2537 · Cited by 301
Titchenell, P. M., Quinn, W. J., Lu, M., Chu, Q., Lu, W., Li, C., Chen, H., Monks, B. R., Chen, J., Rabinowitz, J. D., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.022 · Cited by 281
Genetic determinants of plasma triglycerides
Johansen, C. T., Kathiresan, S., & Hegele, R. A. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r009720 · Cited by 263
Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids
Vatner, D. F., Majumdar, S. K., Kumashiro, N., Petersen, M. C., Rahimi, Y., Gattu, A. K., Bears, M., Camporez, J.-P. G., Cline, G. W., Jurczak, M. J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423952112 · Cited by 235 · cited 1×
“Another mechanism that may contribute to the paradox is that glucose or gluconeogenic substrate delivered to the liver can activate hepatic DNL independently of insulin signaling (16–19).”
BackgroundShort‐term control of glucokinase activity: role of a regulatory protein
Van Schaftingen, E., Detheux, M., & Da Cunha, M. V. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.6.8168691 · Cited by 232
Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat
Schwarz, J.-M., Noworolski, S. M., Wen, M. J., Dyachenko, A., Prior, J. L., Weinberg, M. E., Herraiz, L. A., Tai, V. W., Bergeron, N., Bersot, T. P., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3678 · Cited by 229
Hyperinsulinemic–Euglycemic Clamp to Assess Insulin Sensitivity In Vivo
Kim, J. K. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-59745-448-3_15 · Cited by 213
Self-citationNovel insights into ChREBP regulation and function
Filhoulaud, G., Guilmeau, S., Dentin, R., Girard, J., & Postic, C. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.01.003 · Cited by 210
Haas, J. T., Miao, J., Chanda, D., Wang, Y., Zhao, E., Haas, M. E., Hirschey, M., Vaitheesvaran, B., Farese, R. V., Kurland, I. J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.002 · Cited by 210
Insulin's direct effects on the liver dominate the control of hepatic glucose production
Edgerton, D. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27073 · Cited by 196
Iizuka, K., Miller, B., & Uyeda, K. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00027.2006 · Cited by 195
van SCHAFTINGEN, E. (1989) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1989.tb14538.x · Cited by 193
Trinh, K. Y., O'Doherty, R. M., Anderson, P., Lange, A. J., & Newgard, C. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31615 · Cited by 191
Dentin, R., Tomas-Cobos, L., Foufelle, F., Leopold, J., Girard, J., Postic, C., & Ferré, P. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.07.019 · Cited by 177
Samuel, V. T., Beddow, S. A., Iwasaki, T., Zhang, X.-M., Chu, X., Still, C. D., Gerhard, G. S., & Shulman, G. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812547106 · Cited by 176
Pajvani, U. B., Qiang, L., Kangsamaksin, T., Kitajewski, J., Ginsberg, H. N., & Accili, D. (2013) · Nature Medicine · doi:10.1038/nm.3259 · Cited by 168
Koo, H.-Y., Wallig, M. A., Chung, B. H., Nara, T. Y., Cho, B. H. S., & Nakamura, M. T. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.02.007 · Cited by 164
Determination of glucose-6-phosphatase activity using the glucose dehydrogenase-coupled reaction
Alegre, M. T., Ciudad, C. J., Fillat, C., & Guinovart, J. J. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90176-5 · Cited by 140
Kotani, K., Peroni, O. D., Minokoshi, Y., Boss, O., & Kahn, B. B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421341 · Cited by 139
Sindelar, D. K., Balcom, J. H., Chu, C. A., Neal, D. W., & Cherrington, A. D. (1996) · Diabetes · doi:10.2337/diab.45.11.1594 · Cited by 134 · cited 2×
“However, this contrasts with other studies indicating that insulin’s acute effect of reducing glucose production is mediated through insulin’s actions directly on the liver (10, 11).”
BackgroundResultFOXO1-Mediated Activation of Akt Plays a Critical Role in Vascular Homeostasis
Dharaneeswaran, H., Abid, M. R., Yuan, L., Dupuis, D. E., Beeler, D. L., Spokes, K., Janes, L., Sciuto, T. E., Kang, P. M., Jaminet, S.-C. S., et al. (2014) · Circulation Research · doi:10.1161/circresaha.115.303227 · Cited by 132
Pfefferkorn, J. A., Guzmán-Pérez, A., Litchfield, J., Aiello, R. J., Treadway, J. L., Pettersen, J. C., Minich, M. L., Filipski, K. J., Jones, C. S., Tu, M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2014887 · Cited by 120
Arden, C., Tudhope, S. J., Petrie, J. L., Al-Oanzi, Z. H., Cullen, K. S., Lange, A. J., Towle, H. C., & Agius, L. (2012) · Biochemical Journal · doi:10.1042/bj20111280 · Cited by 116
von Wilamowitz-Moellendorff, A., Hunter, R. W., García-Rocha, M., Kang, L., López-Soldado, I., Lantier, L., Patel, K., Peggie, M. W., Martínez-Pons, C., Voss, M., et al. (2013) · Diabetes · doi:10.2337/db13-0880 · Cited by 106
Ramadoss, P., Abraham, B. J., Tsai, L., Zhou, Y., Costa-e-Sousa, R. H., Ye, F., Bilban, M., Zhao, K., & Hollenberg, A. N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.521450 · Cited by 104
Kursawe, R., Caprio, S., Giannini, C., Narayan, D., Lin, A., D’Adamo, E., Shaw, M., Pierpont, B., Cushman, S. W., & Shulman, G. I. (2013) · Diabetes · doi:10.2337/db12-0889 · Cited by 99
Metabolic effects of oral glucose in the liver of fasted rats
Niewoehner, C. B., Gilboe, D. P., & Nuttall, F. Q. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.246.1.e89 · Cited by 95
Pathway-selective Insulin Resistance and Metabolic Disease: The Importance of Nutrient Flux
Otero, Y. F., Stafford, J. M., & McGuinness, O. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.576355 · Cited by 94
Davies, M. N., O'Callaghan, B. L., & Towle, H. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801539200 · Cited by 93
Cross-regulation of hepatic glucose metabolism via ChREBP and nuclear receptors
Poupeau, A., & Postic, C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.03.015 · Cited by 85
The Role of the Carbohydrate Response Element-Binding Protein in Male Fructose-Fed Rats
Erion, D. M., Popov, V., Hsiao, J. J., Vatner, D., Mitchell, K., Yonemitsu, S., Nagai, Y., Kahn, M., Gillum, M. P., Dong, J., et al. (2013) · Endocrinology · doi:10.1210/en.2012-1725 · Cited by 84
Sex differences in lipid and glucose kinetics after ingestion of an acute oral fructose load
Tran, C., Jacot-Descombes, D., Lecoultre, V., Fielding, B. A., Carrel, G., Lê, K.-A., Schneiter, P., Bortolotti, M., Frayn, K. N., & Tappy, L. (2010) · British Journal of Nutrition · doi:10.1017/s000711451000190x · Cited by 83
Rodríguez‐Calvo, R., Barroso, E., Serrano, L., Coll, T., Sánchez, R. M., Merlos, M., Palomer, X., Laguna, J. C., & Vázquez‐Carrera, M. (2009) · Hepatology · doi:10.1002/hep.22570 · Cited by 65
Agius, L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.09.019 · Cited by 62
Zhu, A., Romero, R., & Petty, H. R. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.02.009 · Cited by 56
A noninvasive method to measure splanchnic glucose uptake after oral glucose administration.
Ludvik, B. H., Nolan, J. J., Roberts, A. J., Baloga, J., Joyce, M., Bell, J., & Olefsky, J. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117913 · Cited by 53
Metabolic effects of oral fructose in the liver of fasted rats
Niewoehner, C. B., Gilboe, D. P., Nuttall, G. A., & Nuttall, F. Q. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.4.e505 · Cited by 50
Li, M. V., Chen, W., Poungvarin, N., Imamura, M., & Chan, L. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0560 · Cited by 47
Fukasawa, M., Ge, Q., Wynn, R., Ishii, S., & Uyeda, K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.115 · Cited by 38
Tissue Specific Effects of Dietary Carbohydrates and Obesity on ChREBPα and ChREBPβ Expression
Stamatikos, A., da Silva, R. P., Lewis, J. T., Douglas, D. N., Kneteman, N. M., Jacobs, R. L., & Paton, C. M. (2015) · Lipids · doi:10.1007/s11745-015-4090-0 · Cited by 29
Micro-method for preparing perchloric extracts of blood.
Humphreys, S. M., & Frayn, K. N. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.8.1657 · Cited by 23
Cited by
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
Jensen, T., Abdelmalek, M. F., Sullivan, S., Nadeau, K. J., Green, M., Roncal, C., Nakagawa, T., Kuwabara, M., Sato, Y., Kang, D.-H., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.019 · Cited by 941
“The stimulation of ChREBP results in the stimulation of glucose-6phosphatase that may mediate some of the gluconeogenic effects of fructose.(112) We also documented that fructose-induced uric acid can impair fatty acid oxidation.”
The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids
Jang, C., Hui, S., Lu, W., Cowan, A. J., Morscher, R. J., Lee, G., Liu, W., Tesz, G. J., Birnbaum, M. J., & Rabinowitz, J. D. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.12.016 · Cited by 639
“Another possible mechanism by which fructose may induce liver toxicity is via itself reaching the liver (Kim et al., 2016; Zhang et al., 2017).”
BackgroundFructose metabolism and metabolic disease
Hannou, S. A., Haslam, D. E., McKeown, N. M., & Herman, M. A. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96702 · Cited by 561
“We recently demonstrated that ingesting fructose, but not glucose, acutely and robustly induces hepatic expression of the potent ChREBP-β isoform along with its lipogenic, fructolytic, and glycolytic targets (133, 134).”
BackgroundInfluentialSelf-citationInsulin signaling in health and disease
Saltiel, A. R. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142241 · Cited by 446
Unraveling the Regulation of Hepatic Metabolism by Insulin
Titchenell, P. M., Lazar, M. A., & Birnbaum, M. J. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.03.003 · Cited by 437
“Dietary fructose administration induces hepatic steatosis, an effect dependent on ChREBP [26].”
Background
Metadata
- Authors
- Kim, M.-S., Krawczyk, S. A., Doridot, L., Fowler, A. J., Wang, J. X., Trauger, S. A., Noh, H.-L., Kang, H. J., Meissen, J. K., Blatnik, M., Kim, J. K., Lai, M., & Herman, M. A.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- University of Massachusetts Chan Medical School (US)
- Pfizer (United States) (US)
- Broad Institute (US)
- Corresponding author
- Herman, Mark A.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2016-09-26
- Volume
- 126
- Issue
- 11
- Pages
- 4372-4386
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5096918
- OpenAlex
- W2521958286
- Cited by
- 212
- References
- 69
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 12 · 2023: 21 · 2022: 24 · 2021: 21 · 2020: 32 · 2019: 30 · 2018: 15 · 2017: 21 · 2016: 2
- FWCI
- 23.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- National Institutes of Health (5u2cdk093000-11)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057521, U24DK093000, U2C-DK093000, R01DK100425, K23DK083439, T32DK007516)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- ChREBP, fructose, hepatic glucose production, hepatic insulin resistance, glucose-6-phosphatase, glucose-6-phosphate, FOXO1, hepatic steatosis, hypertriglyceridemia, hyperinsulinemia, impaired glucose tolerance, de novo lipogenesis, glycolytic genes, carbohydrate metabolism
- MeSH terms
- Forkhead Box Protein O1, Animals, Fatty Liver, Female, Fructose, Glucose, Glucose-6-Phosphatase, Glycolysis, Humans, Insulin, Insulin Resistance, Male, Nuclear Proteins, Transcription Factors, Signal Transduction, Glucose Intolerance, Mice, Knockout, Lipogenesis, Mice, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.